Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...

Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds ...

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

Several Big Pharma companies unveiled price increases for some 250 drugs during the first month of the year, according to data from 3 Axis Advisors. Most notably, Pfizer is raising the price of its ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Jaderberg has been busy tapping up his contacts in big pharma having previously worked as chief medical officer for Bristol Myers Squibb in Europe. He has already been in talks with manufacturers ...

Here are 5 tips designed to help pharma marketers set a tone for their messaging this year, as suggested by a group of their peers.

The story of Eli Lilly and Novo Nordisk’s GLP-1 dominance is likely to play out again in 2025 as the metabolic medicine ...

Pharmaceutical companies are raising the price of over 250 brand drugs this year. Nearly all the price increases are under 10 ...

How has the relationship between Big Pharma and biotech evolved? And where do CROs fit into the mix? Dearth of VC funding forcing difficult biotech decisions The realities of the global economy ...